USANA, Nu Skin and Primerica report reduced sales but CEOs remain optimistic for long-term growth By: Dave Rauf USANA We listen in on the public company earnings calls and read the transcripts so you don’t have to. Check back each quarter for our review with insights and takeaways for your
This content is restricted to site members. If you are an existing user, please log in. New users may register below.